Cartesian Therapeutics, Inc. · NASDAQ:RNAC
Squarepoint Ops LLC reported a 8.30% stake in Cartesian Therapeutics, Inc. (Schedule 13G)
Event Mar 9, 2026 · Filed Mar 13, 2026
Squarepoint Ops LLC reported a 8.30% stake in Cartesian Therapeutics, Inc., 2,209,601 shares, as a passive investor on Mar 9, 2026. Filed Mar 13, 2026 (Schedule 13G).
- Stake
- 8.30%
- Shares
- 2,209,601
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Squarepoint Ops LLC | 8.30% | 2,209,601 |
| Squarepoint Capital LLP | 8.30% | 2,209,601 |
| Squarepoint Operations Private Limited | 8.30% | 2,209,601 |
| Squarepoint (DIFC) Ltd | 8.30% | 2,209,601 |
| Squarepoint Master Fund Limited | 8.20% | 2,178,652 |
| Squarepoint Core Master Fund Limited | 0.10% | 30,949 |